These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 1750517)

  • 21. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
    Ortiz MC; Fortepiani LA; Martínez-Salgado C; Eleno N; Atucha NM; López-Novoa JM; García-Estañ J
    Nefrologia; 2001; 21(6):556-64. PubMed ID: 11881425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of renal perfusion pressure on renal interstitial hydrostatic pressure and Na+ excretion: role of endothelium-derived nitric oxide.
    Nakamura T; Alberola AM; Salazar FJ; Saito Y; Kurashina T; Granger JP; Nagai R
    Nephron; 1998; 78(1):104-11. PubMed ID: 9453411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide and renal effects of volume expansion in conscious monkeys.
    Peterson TV; Carter AB; Miller RA
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1033-8. PubMed ID: 9139998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcitonin gene-related peptide reduces renal vascular resistance and modulates ET-1-induced vasoconstriction.
    Amuchastegui CS; Remuzzi G; Perico N
    Am J Physiol; 1994 Nov; 267(5 Pt 2):F839-44. PubMed ID: 7977788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide.
    Salazar FJ; Pinilla JM; López F; Romero JC; Quesada T
    Hypertension; 1992 Jul; 20(1):113-7. PubMed ID: 1618546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of interactions between nitric oxide and angiotensin II on pressure diuresis and natriuresis.
    Madrid MI; García-Salom M; Tornel J; De Gasparo M; Fenoy FJ
    Am J Physiol; 1997 Nov; 273(5):R1676-82. PubMed ID: 9374809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism underlying diuretic effect of L-NAME at a subpressor dose.
    Liang M; Berndt TJ; Knox FG
    Am J Physiol Renal Physiol; 2001 Sep; 281(3):F414-9. PubMed ID: 11502590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between nitric oxide and renal nerves on pressure-diuresis and natriuresis.
    Madrid MI; Salom MG; Tornel J; López E; Fenoy FJ
    J Am Soc Nephrol; 1998 Sep; 9(9):1588-95. PubMed ID: 9727366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin.
    Kuo JJ; Jones OB; Hall JE
    Hypertension; 2001 Feb; 37(2 Pt 2):670-6. PubMed ID: 11230354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal vascular and tubular actions of calcitonin gene-related peptide: effect of NG-nitro-L-arginine methyl ester.
    Elhawary AM; Pang CC
    J Pharmacol Exp Ther; 1995 Apr; 273(1):56-63. PubMed ID: 7714812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms involved in the cardiovascular-renal actions of nitric oxide inhibition.
    Manning RD; Hu L; Williamson TD
    Hypertension; 1994 Jun; 23(6 Pt 2):951-6. PubMed ID: 8206634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine-2 receptor blockade potentiates the renal effects of nitric oxide inhibition in humans.
    Montanari A; Tateo E; Fasoli E; Donatini A; Cimolato B; Perinotto P; Dall'Aglio P
    Hypertension; 1998 Jan; 31(1 Pt 2):277-82. PubMed ID: 9453316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of big endothelin-1-induced diuresis and natriuresis : role of ET(B) receptors.
    Hoffman A; Abassi ZA; Brodsky S; Ramadan R; Winaver J
    Hypertension; 2000 Mar; 35(3):732-9. PubMed ID: 10720587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of angiotensin II in L-NAME-induced systemic and renal hemodynamic effects in hydrochlorothiazide-pretreated hypertensive subjects.
    van der Linde NA; van den Meiracker AH; Boomsma F
    J Hypertens; 2003 Feb; 21(2):345-51. PubMed ID: 12569265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME.
    Broere A; Van Den Meiracker AH; Boomsma F; Derkx FH; Veld AJ; Schalekamp MA
    Am J Physiol; 1998 Dec; 275(6):F870-7. PubMed ID: 9843903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
    Bech JN; Nielsen CB; Pedersen EB
    Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats.
    Danielson LA; Conrad KP
    J Clin Invest; 1995 Jul; 96(1):482-90. PubMed ID: 7542284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide modulates the development and surgical reversal of renovascular hypertension in rats.
    Huang WC; Tsai RY; Fang TC
    J Hypertens; 2000 May; 18(5):601-13. PubMed ID: 10826564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of nitric oxide in the arterial pressure and renal adaptations to long-term changes in sodium intake.
    Manning RD; Hu L; Reckelhoff JF
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1162-9. PubMed ID: 9140016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of intrarenal nitric oxide in the natriuretic response to dopamine-receptor activation.
    Venkatakrishnan U; Chen C; Lokhandwala MF
    Clin Exp Hypertens; 2000 Apr; 22(3):309-24. PubMed ID: 10803736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.